Global Mycoplasma Pneumonia Test kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Mycoplasma Pneumonia Test kits market size was valued at US$ 944 million in 2024 and is forecast to a readjusted size of USD 1672 million by 2031 with a CAGR of 8.6% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Mycoplasma pneumoniae is a common pathogen that causes primary atypical pneumonia and other respiratory infections. 11% of adult pharyngitis and 33% of pediatric pharyngitis are caused by MP, and 10% to 20% of acute bronchitis and 3% to 5% of bronchiolitis patients have positive serum MP. Severe mycoplasma pneumoniae can lead to death. Mycoplasma Pneumonia Test kits are highly sensitive and specific, and are used to differentiate and diagnose Mycoplasma pneumoniae infection, providing a etiological diagnosis basis for clinical medication.
This report is a detailed and comprehensive analysis for global Mycoplasma Pneumonia Test kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mycoplasma Pneumonia Test kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mycoplasma Pneumonia Test kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mycoplasma Pneumonia Test kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Scientific, GeneProof, SERION Diagnostics, MERIDIAN BIOSCIENCE, Atila BioSystems, Advanced Molecular Diagnostics, Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Shanghai Bojie Medical Technology, Jiangsu Mole BioScience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mycoplasma Pneumonia Test kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Colloidal Gold
ELISA
Fluorescent PCR
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Thermo Scientific
GeneProof
SERION Diagnostics
MERIDIAN BIOSCIENCE
Atila BioSystems
Advanced Molecular Diagnostics
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Shanghai Bojie Medical Technology
Jiangsu Mole BioScience
Qingdao Hightop Biotech Co.,Ltd.
Nanjing Vazyme Medical Technology
Innovita Biological Technology
Guangdong Hexin Health Technology
Coyote Bioscience
Beijing GeneDetective Medical Technology
Wuhan Zhongzhi Biotechnologies
Shanghai Rendu Biological Technology
Daan Gene
Bao Ruiyuan Biotech
Xiamen Amplly Biotechnology
ACON Laboratories
Shenzhen Yilifang Biotech
Shanghai ZJ Bio-Tech
Zhengzhou Antu Bio-Engineering
BioPerfectus
Core Technology
JOYSBIO
Haitian Lanbo Biotech
Chengdu Kanghua Biological Products
Beijing Bell Biotechnology
Bioneovan
Sanming Bofeng Biotechnology
Beijing North Institute of Biotechnology
Xiamen Wiz Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mycoplasma Pneumonia Test kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mycoplasma Pneumonia Test kits, with price, sales quantity, revenue, and global market share of Mycoplasma Pneumonia Test kits from 2020 to 2025.
Chapter 3, the Mycoplasma Pneumonia Test kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mycoplasma Pneumonia Test kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mycoplasma Pneumonia Test kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mycoplasma Pneumonia Test kits.
Chapter 14 and 15, to describe Mycoplasma Pneumonia Test kits sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Mycoplasma pneumoniae is a common pathogen that causes primary atypical pneumonia and other respiratory infections. 11% of adult pharyngitis and 33% of pediatric pharyngitis are caused by MP, and 10% to 20% of acute bronchitis and 3% to 5% of bronchiolitis patients have positive serum MP. Severe mycoplasma pneumoniae can lead to death. Mycoplasma Pneumonia Test kits are highly sensitive and specific, and are used to differentiate and diagnose Mycoplasma pneumoniae infection, providing a etiological diagnosis basis for clinical medication.
This report is a detailed and comprehensive analysis for global Mycoplasma Pneumonia Test kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mycoplasma Pneumonia Test kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2020-2031
Global Mycoplasma Pneumonia Test kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mycoplasma Pneumonia Test kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mycoplasma Pneumonia Test kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Scientific, GeneProof, SERION Diagnostics, MERIDIAN BIOSCIENCE, Atila BioSystems, Advanced Molecular Diagnostics, Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Shanghai Bojie Medical Technology, Jiangsu Mole BioScience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mycoplasma Pneumonia Test kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Colloidal Gold
ELISA
Fluorescent PCR
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Thermo Scientific
GeneProof
SERION Diagnostics
MERIDIAN BIOSCIENCE
Atila BioSystems
Advanced Molecular Diagnostics
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Shanghai Bojie Medical Technology
Jiangsu Mole BioScience
Qingdao Hightop Biotech Co.,Ltd.
Nanjing Vazyme Medical Technology
Innovita Biological Technology
Guangdong Hexin Health Technology
Coyote Bioscience
Beijing GeneDetective Medical Technology
Wuhan Zhongzhi Biotechnologies
Shanghai Rendu Biological Technology
Daan Gene
Bao Ruiyuan Biotech
Xiamen Amplly Biotechnology
ACON Laboratories
Shenzhen Yilifang Biotech
Shanghai ZJ Bio-Tech
Zhengzhou Antu Bio-Engineering
BioPerfectus
Core Technology
JOYSBIO
Haitian Lanbo Biotech
Chengdu Kanghua Biological Products
Beijing Bell Biotechnology
Bioneovan
Sanming Bofeng Biotechnology
Beijing North Institute of Biotechnology
Xiamen Wiz Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mycoplasma Pneumonia Test kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mycoplasma Pneumonia Test kits, with price, sales quantity, revenue, and global market share of Mycoplasma Pneumonia Test kits from 2020 to 2025.
Chapter 3, the Mycoplasma Pneumonia Test kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mycoplasma Pneumonia Test kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mycoplasma Pneumonia Test kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mycoplasma Pneumonia Test kits.
Chapter 14 and 15, to describe Mycoplasma Pneumonia Test kits sales channel, distributors, customers, research findings and conclusion.
Table of Contents
195 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Mycoplasma Pneumonia Test kits by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
